* Osoby mające problemy z tarczycą nie powinny przyjmować dużych dawek kwercetyny. Badania in vitro wykazały, że kwercetyna i inne flawonoidy zakłócają syntezę hormonów tarczycy. U kobiet wysokie spożycie soi było związane z podwyższonym stężeniem TSH tarczycy, może to zależeć od dawki, dlatego w przypadku przewlekłego stosowania profilaktycznego sugerujemy przyjmowanie najmniejszą dawkę. Kwercetynę należy stosować ostrożnie u pacjentów z niedoczynnością tarczycy. Poziom TSH powinien być monitorowany. Należy również zwrócić uwagę na fakt, że kwercetyna może wchodzić w istotne interakcje interakcje. Najważniejszą interakcją jest interakcja z cyklosporyną i takrolimusem. U pacjentów przyjmujących te leki najlepiej jest unikać kwercetyny; jeśli kwercetyna jest przyjmowana, należy kontrolować stężenie cyklosporyny i takrolimusu.
** Nie podawaj dzieciom poniżej 12 roku życia. Nie łącz jednocześnie z innymi lekami przeciwzakrzepowymi. W przypadku przyjmowania ibuprofenu lub naproksenu zachowaj odstęp przynajmniej 6 godzin.
Należy unikać długotrwałego stosowania dużych dawek cynku (> 50mg dziennie), ponieważ wiąże się to z niedoborem miedzi.
Tymochinon (aktywny składnik czarnuszki) zmniejsza wchłanianie cyklosporyny i fenytoiny. Pacjenci przyjmujący te leki powinni zatem unikać przyjmowania czarnuszki. Ponadto, zgłoszono dwa przypadki zespołu serotoninowego u pacjentów przyjmujących czarnuszkę, którzy poddani zostali znieczuleniu ogólnemu (prawdopodobna interakcja z fentanylem).
Shneider A, Kudriavtsev A, Vakhusheva A. Can melatonin reduce the severity of COVID-19 pandemic. medRxiv 2020.
Rattis BA, Ramos SG, Celes MR. Curcumin as a potential treatment for COVID-19. Fronteirs in Pharmacology 2021; 21:675287.
Chai YS, Chen YQ, Lin SH et al. Curcumin regulates the differentiation of naive CD4+ T cells and activates IL-10 immune modulation against acute lung injury in mice. Biomedicine and Pharmacotherapy 2020; 125:109946.
Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C et al. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021; 7:e06350.
Jena AB, Kanungo N, Nayak V et al. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Scientific Reports 2021; 11:2043.
Somi VK, Mehta A, Ratre YK et al. Curcumin, a traditional spice component, can hold promise against COVID-10? Eur J Pharmacol 2020; 886:173551.
Tahmasebi S, El-Esawi MA, Mahmoud ZH et al. Immunomodulatory effects of nanocurcumin on the Th17 cell responses in mild and severe COVID-19 patients. J Cell Physiol 2021; 236:5325-38.
Valizadeh H, Danshina S, Gencer MZ et al. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology 2020; 89:107088.
Al-Hatamleh MA, Hatmal MM, Sattat K et al. Antiviral and immnomodulatory effects of phytochemicals from honey against COVID-19: Potential mechanisms of action and future directions. Molecules 2020; 25:5017.
Hashem HE. In Silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors. medRxiv 2021.
Ashraf S, Ashraf S, Ashraf M et al. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial. medRxiv 2021.
Salim B, Noureddine M. Identification of compounds from Nigella Sativa as new potential inhibitors of 2019 Novel Coronavirus (COVID-10): Molecular docking study. ChemRxiv 2021.
Fakhar-e-Alam Kulyar M, Li R, Mehmood K et al. Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic. Phytomedicine 2021; 85:153277.
Khazdair MR, Ghafari S, Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharmaceutical Biology 2021; 59:696-703.
Islam MN, Hossain KS, Sarker PP et al. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytotherapy Research 2021; 35:1329-44.
Rahman MT. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19. J Herbal Med 2020; 23:100382.
Hannan MA. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021; 13.
Maghbooli Z, Sahraian MA, Ebrahimi M et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/ml reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PloS ONE 2020; 15:e0239799.
Grant WB, Lahore H, McDonnell SL et al. Evidence that Vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12:988.
Kaufman HW, Niles JK, Kroll MH et al. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D level. PloS ONE 2020; 15:e0239252.
Lau FH, Majumder R, Torabi R et al. Vitamin D insufficiency is prevalent in severe COVID-19. medRxiv 2020.
Marik PE, Kory P, Varon J. Does vitamin D status impact mortlality from SARS-CoV-2 infection? Medicine in Drug Discovery 2020.
Rhodes JM, Subramanian S, Laird E et al. Editorial: Low population mortality from COVID-19 in countries south of 35 degrees North - supports vitamin D as a factor determining severity. Alimentary Pharmacology & Therapeutics 2020; (in press).
Dancer RC, Parekh D, Lax S et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax 2015; 70:617-24.
LLie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 2020.
Daneshkhah A, Eshein A, Subramanian H. The role of vitamin D in suppressing cytokine storm of COVID-19 patients and associated mortality. medRxiv 2020.
Bergman P, Lindh AU, Bjorkhem-Bergman L et al. Vitamin D and respiartory tract infections: A systematic review and meta-analysis of randomized controlled trials. PloS ONE 2013; 8:e65835.
Carpagnano GE, Lecce V, Quaranta VN et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory fialure due to COVID-19. J Endocrinol Invest 2020.
Israel A, Cicurel A, Feldhamer I et al. The link between vitamin D deficiency and Covid-19 in a large population. medRxiv 2020.
Radujkovic A, Hippchen T, Tiwari-Heckler S et al. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 2020; 12:2757.
Rizzoli R. Vitamin D supplementation: upper limit for safety revisited. Aging Clin Exp Res 2020.
Annweiler C, Hanotte B, de L'Eprevier CG et al. Vitamin D and survival in COVID-19 patients: A quasi-experimental study. Journal of Steroid Biochemistry & Molecular Biology 2020.
Moozhipurath RK, Kraft L, Skiera B. Evidence of protective role of Ultraviolet-B (UVB) radiation in reducing COVID-19 deaths. Nature Research 2020; 10:17705.
Cangiano B, Fatti LM, Danesi L et al. Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementaion, and limitations of the diagnostic tests. Aging 2020; 12.
De Smet D, De Smet K, Herroelen P et al. Serum 25(OH)D level on hospital admission assocaited with COVID-19 stage and mortality. Am J Clin Pathol 2020.
Cozier YC, Castro-Webb N, Hochberg NS et al. Lower serum 25(OH) D levles associated with higher risk of COVID-19 infection in U.S. black women. PloS ONE 2021; 16:e0255132.
Murai IH, Fernandes AL, Sales LP et al. Effect of vitamin D3 supplementaion vs placebo on hospital length of stay in patients with severe COVID-19: A multicenter, double-blind, randomized controlled trial. JAMA 2020.
Wu Y, Cheng X, Jiang G et al. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. npj Biofilms and Microbiomes 2021; 7:61.
Hazan S, Stollman N, Bozkurt H et al. The missing microbes: Bifidobacterium and Faecalibacterium depletion and loss of microbiome diversity as potential susceptibility markers for SARS-CoV-2 infection and severity. Clinical Gastroenterology & Hepatology 2021.
Din AU, Mazhar M, Waseem M et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotic role. Biomedicine & Pharmacotherapy 2021; 133:110947.
Yeoh YK, Zuo T, Lui GC et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021; 70:698-706.
Rosa DD, Dias MM, Grzeskowiak LM et al. Milk kefir: nutritional, micobiological and health benefits. Nutrition Research Reviews 2017; 30:82-96.
Kim DH, Jeong D, Kim H et al. Modern perspectives on the health benefits of kefir in next generation sequencing era: Improvement of the host gut microbiota. Critical Reviews in Food Science and Nutrition 2019; 59:1782-93.
Maggini S, Beveridge S, suter M. A combination of high-dose vitamin C plus zinc for the common cold. Journal of International Medical Research 2012; 40:28-42.
Colunga Biancatelli RM, Berrill M, Catravas JD et al. Quercetin and Vitamin C: experimental therapy for the prevention and treatment of SARS-CoV-2 via synergistic action. Front Immunol 2020.
Kyung Kim T, Lim HR, Byun JS. Vitamin C supplementaion reduces the odds of developing a common cold in Republic of Korea Army recruits: a randomised controlled trial. BMJ Mil Health 2020.
Colunga Biancatelli RM, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther 2020; 18:99-101.
Hiedra R, Lo KB, Elbashabsheh M et al. The use of IV vitamin C for patients with COVID-19: a case series. Exp Rev Anti Infect Ther 2020.
Chen L, Li J, Luo C et al. Binding interaction of quercetin-3-B-galactoside and its synthetic derivatives with SARS-CoV 3CL: structure-activity relationship reveal salient pharmacophore features. Bioorganic & Medicinal Chemistry Letters 2006; 14:8295-306.
Nain Z, Rana HK, Lio P et al. Pathogenic profiling of COVID-19 and SARS-like viruses. Briefings in Bioinformatics 2020.
Yi L, Li Z, Yuan K et al. Small molecules blocking the entry of severe respiratory syndrome coronavirus into host cells. J Virol 2020; 78:11334-39.
Shakoor H, Feehan J, Dhaheri AS et al. Immune-boosting role of vitamins D,C,E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19. Maturitas 2020.
Abian O, Ortega-Alarcon D, Jimenez-Alesanco A et al. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. International Journal of Biological Macromolecules 2020; 164:1693-703.
Hemila H, Carr A, Chalker E. Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z randomized clinical trial. Research Square 2021.
Marik PE. Hydrocortisone, Ascorbic Acid and Thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid. Nutrients 2018; 10:1762.
Marik PE. Vitamin C for the treatment of sepsis: The scientific rationale. Pharmacol Therapeut 2018; 189:63-70.
Chen L, Li J, Luo C et al. Binding interaction of quercetin-3-B-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure-activity relationship studies revela salient pharmacophore features. Bioorganic & Medicinal Chemistry 2020; 14:8295-306.
Ono K, Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem 1990; 108:609-13.
Nair MP, Kandaswami C, Mahajan S et al. The flavonoid, quercetin, differentially regulates Th-1 (INF) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochimica et Biophysica Acta 2020; 1593:29-36.
Saeedi-Boroujeni A, Mahmoudian-Sani MR. Anti-inflammatory potential of Quercetin in COVID-19 treatment. J Inflamm 2021; 18:3.
Dabbagh-Bazarbachi H, Clergeaud G, Quesada IM et al. Zinc ionophore activity of Quercetin and Epigallocatechin-gallate:From Hepa 1-6 cells to a liposome model. J Agric Food Chem 2014; 62:8085-93.
Nieman DC, Simonson A, Sakaguchi CA et al. Acute Ingestion of a Mixed Flavonoid and Caffeine Supplement Increases Energy Expenditure and Fat Oxidation in Adult Women: A Randomized, Crossover Clinical Trial. Nutrients 2019; 11.
Giuliani C, Bucci I, Di Santo S et al. The flavonoid quercetin in hibits thyroid-restricted genes expression and thyroid function. Food and Chemical Toxicology 2014; 66:23-29.
de Souza dos Santos MC, Goncalves CF, Vaisman M et al. Impact of flavonoids on thyroid function. Food and Chemical Toxicology 2011; 49:2495-502.
Chandra AK, De N. Catechin induced modulation in the activities of thyroid hormone synthesizing enzymes leading to hypothyroidism. Mol Cell Biochem 2013; 374:37-48.
Pistollato F, Masias M, Agudo P et al. Effects of phytochemicals on thyroid function and their possible role in thyroid disease. Ann N Y Acad Sci 2019; 1433:3-9.
Sathyapalan T, Manuchehri AM, Thatcher NJ et al. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: A randomized, double-blind, crossover study. J Clin Endocrinol Metab 2020; 96:1422-49.
Tonstad S, Jaceldo-Siegl K, Messina M et al. The association between soya consumption and serum thyroid-stimulating hormone in the Adventist Health Study-2. Public Health Nutr 2016; 19:1464-70.
Colombo D, Lunardon L, Bellia G. Cyclosporine and herbal supplement interactions. Journal of Toxicology 2014; 2014:145325.
Vogel-Gonzalez M, Tallo-Parra M, Herrera-Fernandez V et al. Low zinc levels at admission associates with poor clinical outcomes in SARS-CoV-2 infection. Nutrients 2021; 13:562.
te Velthuis AJ, van den Worm SH, Sims AC et al. Zn2+ inhibits Coronavirus and Arterivirus RNA polymerase activity In Vitro and Zinc ionophores block the replication of these viruses in cell culture. PLos Pathog 2010; 6:e1001176.
Shakoor H, Freehan J, Mikkelsen K et al. Be well: A potential role for vitamin B in COVID-19. Maturitas 2020.
dos Santos LM. Can vitamin B12 be an adjuvant to COVID-19 treatment? GSC Biological and Pharmaceutical Sciences 2020; 11.
Tan CW, Ho LP, Kalimuddin S et al. Cohort study to evaluate effect of vitamin D, magnesium, and vitamin b12 in combination on severe outcome progression in older patients with coronavirus (COVID-19). Nutrition 2020; 80:111017.
Zhang P, Tsuchiya K, Kinoshita T et al. Vitamin B6 prevents IL-1B protein production by inhibiting NLRP3 inflammasome activation. J Biol Chem 2020; 291:24517-27.
Bianconi V, Violi F, Fallarino F et al. Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19? Drugs 2020.
Muller C, Karl N, Ziebuhr J et al. D,L-lysine acetylsalicylate + glycine impairs coronavirus replication. J Antivir Antiretovir 2020.
Cakman I, Kirchner H, Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 1997; 17:469-72.
Cheng RZ. Can early and high-dose vitamin C prevent and treat coronavirus disease 2019 (COVID-19). Medicine in Drug Discovery 2020.
Wang Y, Lin H, Lin BW et al. Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis. Ann Intensive Care 2019; 9:58.
Boretti A, Banik BK. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome. PharmaNutrition 2020; 12:100190.
Iglesias J, Vassallo AV, Patel V et al. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis. Chest 2020; 158:164-73.
de Melo AF, Homem-de-Mello M. High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection. Crit Care 2020; 24:500.
Zhang J, Rao X, Li Y et al. High-dose vitamin C infusion for the treatment of critically ill COVID-19. Research Square 2020.
Kumari P, Dembra S, Dembra P et al. The role of vitamin C as adjuvant therapy in COVID-19. Cureus 2020; 12:e11779.
Al Sulaiman K, Al Juhani O, Badreldin HA et al. Adjunctive therapy with ascorbic in critically ill patients with COVID-19: A multicenter propensity score matched study. Crit Care 2021.
Lankadeva YR, Peiris RM, Okazaki N et al. Reversal of the pathophysiological responses to Gram-negative sepsis by megadose Vitamin C. Crit Care Med 2020.
Zhang J, Rao X, Li Y et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intenisve Care 2020.
Patterson G, Isales CM, Fulzele S. Low level of vitamin C and dysregulation of vitamin C transporter might be involved in the severity of COVID-19 infection. Aging and Disease 2020; 12.
Tomassa-Irriguible TM, Lielsa-Berrocal L. COVID-19: Up to 87% critically ill patients had low vitamin C values. Research Square 2020.
Arvinte C, Singh M, Marik PE. Serum levels of vitamin C and vitamin D in a cohort of critically ill COVID-19 patients of a North American Community Hospital Intensive Care Unit in May 2020. A pilot study. Medicine in Drug Discovery 2020; 8:100064.
Menezes RR, Godin AM, Rodrigues FF et al. Thiamine and riboflavin inhibit production of cytokines and increase the anti-inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete Freund's adjuvant. Pharmacological Reports 2020; 69:1036-43.
Vatsalya V, Li F, Frimodig J et al. Therapeutic prospects for Th-17 cell immune storm syndrome and neurological symptoms in COVID-19: Thiamine efficacy and safety, In-vitro evidence and pharmacokinetic profile. medRxiv 2020.
Mallat J, Lemyze M, Thevenin D. Do not forget to give thiamine to your septic shock patient! J Thorac Dis 2016; 8:1062-66.
Moskowitz A, Donnino MW. Thiamine (vitamin B1) in septic shock: a targeted therapy. J Thorac Dis 2020; 12 (suppl 1):S78-S83.
Woolum JA, Abner EL, Kelly A et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med 2018; 46:1747-52.
Marik PE. Thiamine: An essential component of the metabolic resuscitation protocol. Crit Care Med 2018; 46:1869-70.
Al Sulaiman K, Aljuhani O, Al Dossari M et al. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: A multicenter propensity score matched study. Research Square 2021.